Table 1 Open in new tab CVI participant...

Table 1

CVI participant demographics.

Participant ID	Etiology; Comorbidities	Age (years)	Sex	Preterm/Term	Binocular Visual Acuity (Snellen)	Binocular Visual Acuity (LogMAR)	Functional Classification	Global (Total) Lesion Score (n/48)
1	in-utero stroke; cerebral palsy	14	female	preterm	20/25	0.10	3	0.5
2	ischemic hypoxic ischemia	23	female	preterm	20/40	0.30	3	3.5
3	meningitis, infarct	20	female	term	20/40	0.30	3	8.5
4	perinatal head injury, hypoglycemia, anoxia	12	female	term	20/20	0.00	3	4
5	birth complication	20	female	term	20/15	−0.12	3	7.5
6	decreased placental perfusion; global developmental delay	23	female	term	20/70	0.54	3	1
7	focal cortical atrophy; seizure disorder	21	male	term	20/40	0.30	3	16
8	unspecified; developmental delay	22	male	preterm	20/25	0.10	2	2.5
9	genetic disorder	18	male	term	20/20	0.00	3	4
10	unspecified; developmental delay	17	male	term	20/25	0.10	3	2
11	periventricular leukomalacia; cerebral palsy	16	male	term	20/20	0.00	3	16.5
12	periventricular leukomalacia; cerebral palsy	31	male	preterm	20/50	0.40	2	27
13	cystic periventricular leukomalacia; cerebral palsy	11	male	preterm	20/30	0.17	3	14
14	periventricular leukomalacia; cerebral palsy	25	male	preterm	20/25	0.10	3	26

Participant ID	Etiology; Comorbidities	Age (years)	Sex	Preterm/Term	Binocular Visual Acuity (Snellen)	Binocular Visual Acuity (LogMAR)	Functional Classification	Global (Total) Lesion Score (n/48)
1	in-utero stroke; cerebral palsy	14	female	preterm	20/25	0.10	3	0.5
2	ischemic hypoxic ischemia	23	female	preterm	20/40	0.30	3	3.5
3	meningitis, infarct	20	female	term	20/40	0.30	3	8.5
4	perinatal head injury, hypoglycemia, anoxia	12	female	term	20/20	0.00	3	4
5	birth complication	20	female	term	20/15	−0.12	3	7.5
6	decreased placental perfusion; global developmental delay	23	female	term	20/70	0.54	3	1
7	focal cortical atrophy; seizure disorder	21	male	term	20/40	0.30	3	16
8	unspecified; developmental delay	22	male	preterm	20/25	0.10	2	2.5
9	genetic disorder	18	male	term	20/20	0.00	3	4
10	unspecified; developmental delay	17	male	term	20/25	0.10	3	2
11	periventricular leukomalacia; cerebral palsy	16	male	term	20/20	0.00	3	16.5
12	periventricular leukomalacia; cerebral palsy	31	male	preterm	20/50	0.40	2	27
13	cystic periventricular leukomalacia; cerebral palsy	11	male	preterm	20/30	0.17	3	14
14	periventricular leukomalacia; cerebral palsy	25	male	preterm	20/25	0.10	3	26